vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是OneStream, Inc.的2.0倍（$321.1M vs $163.7M），OneStream, Inc.净利率更高（0.6% vs -18.2%，领先18.9%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 23.6%），OneStream, Inc.自由现金流更多（$25.6M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
MDGL vs OS — 直观对比
营收规模更大
MDGL
是对方的2.0倍
$163.7M
营收增速更快
MDGL
高出187.2%
23.6%
净利率更高
OS
高出18.9%
-18.2%
自由现金流更多
OS
多$159.5M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $163.7M |
| 净利润 | $-58.6M | $999.0K |
| 毛利率 | — | 69.8% |
| 营业利润率 | -18.6% | -3.2% |
| 净利率 | -18.2% | 0.6% |
| 营收同比 | 210.8% | 23.6% |
| 净利润同比 | 1.4% | — |
| 每股收益（稀释后） | $-2.55 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLOS
| Q4 25 | $321.1M | $163.7M | ||
| Q3 25 | $287.3M | $154.3M | ||
| Q2 25 | $212.8M | $147.6M | ||
| Q1 25 | $137.3M | $136.3M | ||
| Q4 24 | $103.3M | $132.5M | ||
| Q3 24 | $62.2M | $129.1M | ||
| Q2 24 | — | $117.5M | ||
| Q1 24 | $0 | $110.3M |
净利润MDGLOS
| Q4 25 | $-58.6M | $999.0K | ||
| Q3 25 | $-114.2M | $-8.8M | ||
| Q2 25 | $-42.3M | $-18.4M | ||
| Q1 25 | $-73.2M | $-24.0M | ||
| Q4 24 | $-59.4M | — | ||
| Q3 24 | $-107.0M | $-171.9M | ||
| Q2 24 | — | $-7.8M | ||
| Q1 24 | $-147.5M | $-5.0M |
毛利率MDGLOS
| Q4 25 | — | 69.8% | ||
| Q3 25 | — | 68.1% | ||
| Q2 25 | — | 68.6% | ||
| Q1 25 | 96.7% | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% | ||
| Q1 24 | — | 69.1% |
营业利润率MDGLOS
| Q4 25 | -18.6% | -3.2% | ||
| Q3 25 | -39.7% | -11.3% | ||
| Q2 25 | -22.2% | -21.8% | ||
| Q1 25 | -57.8% | -29.3% | ||
| Q4 24 | -64.8% | -35.8% | ||
| Q3 24 | -187.1% | -197.6% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | -4.9% |
净利率MDGLOS
| Q4 25 | -18.2% | 0.6% | ||
| Q3 25 | -39.8% | -5.7% | ||
| Q2 25 | -19.9% | -12.5% | ||
| Q1 25 | -53.4% | -17.6% | ||
| Q4 24 | -57.5% | — | ||
| Q3 24 | -172.0% | -133.1% | ||
| Q2 24 | — | -6.7% | ||
| Q1 24 | — | -4.5% |
每股收益（稀释后）MDGLOS
| Q4 25 | $-2.55 | — | ||
| Q3 25 | $-5.08 | — | ||
| Q2 25 | $-1.90 | — | ||
| Q1 25 | $-3.32 | — | ||
| Q4 24 | $-2.50 | — | ||
| Q3 24 | $-4.92 | $-1.06 | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.38 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $693.6M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $504.7M |
| 总资产 | $1.3B | $1.0B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLOS
| Q4 25 | $198.7M | $693.6M | ||
| Q3 25 | $295.7M | $653.9M | ||
| Q2 25 | $186.2M | $652.1M | ||
| Q1 25 | $183.6M | $593.9M | ||
| Q4 24 | $100.0M | $544.2M | ||
| Q3 24 | $232.7M | $495.5M | ||
| Q2 24 | — | $140.5M | ||
| Q1 24 | $622.5M | — |
总债务MDGLOS
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益MDGLOS
| Q4 25 | $602.7M | $504.7M | ||
| Q3 25 | $625.7M | $472.1M | ||
| Q2 25 | $696.0M | $458.2M | ||
| Q1 25 | $710.6M | $412.9M | ||
| Q4 24 | $754.4M | $386.2M | ||
| Q3 24 | $777.2M | $458.2M | ||
| Q2 24 | — | $97.5M | ||
| Q1 24 | $850.8M | $102.5M |
总资产MDGLOS
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.4B | $949.4M | ||
| Q2 25 | $1.0B | $910.5M | ||
| Q1 25 | $996.6M | $867.3M | ||
| Q4 24 | $1.0B | $823.2M | ||
| Q3 24 | $1.1B | $750.1M | ||
| Q2 24 | — | $379.7M | ||
| Q1 24 | $1.1B | — |
负债/权益比MDGLOS
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $25.8M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $25.6M |
| 自由现金流率自由现金流/营收 | -41.7% | 15.7% |
| 资本支出强度资本支出/营收 | 0.1% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 25.79× |
| 过去12个月自由现金流最近4个季度 | — | $95.6M |
8季度趋势，按日历期对齐
经营现金流MDGLOS
| Q4 25 | $-133.5M | $25.8M | ||
| Q3 25 | $79.8M | $5.0M | ||
| Q2 25 | $-47.1M | $29.7M | ||
| Q1 25 | $-88.9M | $36.2M | ||
| Q4 24 | $-104.5M | — | ||
| Q3 24 | $-67.0M | $2.4M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | $-149.2M | $25.5M |
自由现金流MDGLOS
| Q4 25 | $-133.8M | $25.6M | ||
| Q3 25 | $79.0M | $4.8M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.8M | ||
| Q4 24 | $-104.7M | — | ||
| Q3 24 | $-67.8M | $1.3M | ||
| Q2 24 | — | $7.7M | ||
| Q1 24 | $-149.5M | $24.9M |
自由现金流率MDGLOS
| Q4 25 | -41.7% | 15.7% | ||
| Q3 25 | 27.5% | 3.1% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | -101.3% | — | ||
| Q3 24 | -109.0% | 1.0% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 22.5% |
资本支出强度MDGLOS
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 1.3% | 0.8% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.6% |
现金转化率MDGLOS
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
